PHARMAZIE 润色咨询

PHARMAZIE

出版年份：1946 年文章数：2432 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究<br>经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究<br>经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学<br>经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？ 我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]
    2022-01-06 emmawang

    偏重的研究方向：临床研究
    经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究<br>经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究<br>经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学<br>经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？ 我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]
    2021-12-01 emmawang

    偏重的研究方向：临床研究
    经验分享：投稿8天，在等待中

    9

    展开9条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究<br>经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究<br>经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学<br>经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？ 我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]
    2022-01-04 药剂学萌新

    被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭

    9

    展开9条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究<br>经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究<br>经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学<br>经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？ 我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]
    2021-12-27 rayms

    评审和期刊编辑要求我补实验，就一定要补么，不补行不行？

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究<br>经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究<br>经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学<br>经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？ 我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]
    2021-12-29 msSSSSSD

    对于审稿人好的意见也要回复么？

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究<br>经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究<br>经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学<br>经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？ 我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]
    2020-05-21 榴莲味少女

    最近有没有接收的朋友。。我投稿一个月了一点消息都没有

    17

    展开17条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究<br>经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究<br>经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学<br>经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？ 我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]
    2021-12-29 药剂学萌新

    偏重的研究方向：药动学
    经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究<br>经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究<br>经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学<br>经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？ 我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]
    2021-11-26 1471ca3am71暂无昵称

    一篇综述投了9天后让转投其他专业期刊

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究<br>经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究<br>经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学<br>经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？ 我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]
    2019-10-07 1e0e201bm72(暂无匿称)

    有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究<br>经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究<br>经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学<br>经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？ 我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]
    2020-06-07 榴莲味少女

    请问有没有接收的朋友知道怎么汇出版费？ 我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。

    2

    展开2条回复
共169条页码: 1/17页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分